Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
First Affiliated Hospital of Zhejiang University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Georgetown University
Memorial Sloan Kettering Cancer Center
Nationwide Children's Hospital
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Massachusetts General Hospital
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Massachusetts General Hospital
Assistance Publique - Hôpitaux de Paris
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Chinese PLA General Hospital
The First Affiliated Hospital of Soochow University
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Marmara University